Discover
NKTR
Nektar Therapeutics
74.86
1 x 74.25
1 x 75.99
bid
ask
-
1.62
2.12%
87 @ 04:00 PM
74.80 -0.06 (0.08%)
| Ytd | 77.06% | |
| 1y | 224.63% |
74.33
day range
76.38
22.28
52 week range
109.00
| Open | 76.03 | Prev Close | 76.48 | Low | 74.33 | High | 76.38 | Mkt Cap | 2.15B |
| Vol | 486.84K | Avg Vol | 992.60K | EPS | -8.40 | P/E | -8.91 | Forward P/E | -6.44 |
| Beta | 1.14 | Short Ratio | 5.48 | Inst. Own | 92.05% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 66.59 | 200-d Avg | 63.49 | 1yr Est | 153.22 |
| Income Statement | |||
| Total Revenue | 10.86M | ||
| Revenues (USD) | 10.86M | ||
| Gross Profit | 10.86M | ||
| Operating Expenses | 49.92M | ||
| Research and Development Expense | 35.68M | ||
| Selling, General and Administrative Expense | 13.44M | ||
| Operating Income | -39.05M | ||
| Interest Expense | 7.94M | ||
| Income Tax Expense | 64.00K | ||
| Net Income | -44.90M | ||
| Net Income Common Stock | -44.90M | ||
| Net Income Common Stock (USD) | -44.90M | ||
| Consolidated Income | -44.90M | ||
| Earnings per Basic Share | -1.82 | ||
| Earnings per Basic Share (USD) | -1.82 | ||
| Earnings per Diluted Share | -1.82 | ||
| Earning Before Interest & Taxes (EBIT) | -36.90M | ||
| Earning Before Interest & Taxes (USD) | -36.90M | ||
| Weighted Average Shares | 24.74M | ||
| Weighted Average Shares Diluted | 24.74M | ||
| Balance Sheet | |||
| Cash and Equivalents | 149.58M | ||
| Cash and Equivalents (USD) | 149.58M | ||
| Investments | 582.02M | ||
| Investments Current | 419.03M | ||
| Investments Non-Current | 162.99M | ||
| Current Assets | 589.04M | ||
| Total Assets | 763.27M | ||
| Debt Current | 22.53M | ||
| Total Debt | 83.16M | ||
| Current Liabilities | 57.71M | ||
| Debt Non-Current | 60.63M | ||
| Total Liabilities | 187.06M | ||
| Accumulated Retained Earnings (Deficit) | -3.81B | ||
| Accumulated Other Comprehensive Income | -1.03M | ||
| Shareholders Equity | 576.22M | ||
| Shareholders Equity (USD) | 576.22M | ||
| Assets Non-Current | 174.23M | ||
| Total Debt (USD) | 83.16M | ||
| Liabilities Non-Current | 129.35M | ||
| Trade and Non-Trade Payables | 10.03M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 151.00K | ||
| Net Cash Flow from Financing | 529.55M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 134.46M | ||
| Capital Expenditure | -18.00K | ||
| Issuance (Purchase) of Equity Shares | 529.55M | ||
| Net Cash Flow from Investing | -350.79M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -350.77M | ||
| Net Cash Flow from Operations | -44.30M | ||
| Share Based Compensation | 3.36M | ||